NASDAQ:SIGA · NASDAQ Global Market
-$0.02 today
Vol 0.56M · Avg 0.61M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Company filings are the primary source for understanding what changed inside SIGA Technologies, Inc. before the market fully reacts. Review recent SIGA disclosures alongside price history and peer context to identify new risks, accounting changes, strategic updates, capital allocation decisions, and operating details that may affect the intrinsic value case.
Price History
Dividend-adjusted closing price
Change
-40.53%
Period High
$8.39
Period Low
$3.50
Latest
$3.61
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Olema Pharmaceuticals, Inc.
NASDAQ:OLMA
$1.10B
Rigel Pharmaceuticals, Inc.
NASDAQ:RIGL
$716.40M
Esperion Therapeutics, Inc.
NASDAQ:ESPR
$656.99M
CytomX Therapeutics, Inc.
NASDAQ:CTMX
$614.35M
Emergent BioSolutions Inc.
NYSE:EBS
$427.22M
Aquestive Therapeutics, Inc.
NASDAQ:AQST
$415.10M
SNDL Inc.
NASDAQ:SNDL
$357.91M
Organogenesis Holdings Inc.
NASDAQ:ORGO
$303.67M
DarioHealth Corp.
NASDAQ:DRIO
$53.23M
What is the latest SIGA filing?
The latest filing shown is S-8 dated Jun 25, 2026.
How many recent filings does SIGA have?
Intrinsic Alpha currently shows 20 recent filings for SIGA.
Explore More
Continue the stock analysis
Jump to another research area for this company.